Gates Package — page 69

Progress to Date Aseries of high-level interactive workshops and teleconferences have been held since January 2016 to develop initial proposals for the science and regulation, partnership models and financing considerations of CEPI. Next Steps The following next steps are envisioned: - Finalize task team recommendations for integration into the Strategic and Business Plans - Establish a cross task team cost modeling group - Formalize interim governance arrangements - Convene Leadership Group Meeting in London to present agreed Integrated Strategic/ Business Plan - Tender the concept with G7 Health Ministers in Japan - Broaden advocacy and secure initial funding commitments for launch at the Annual Meeting at Davos in January 2017 Leadership Group Members Name Role Interaction 30 August Stakeholder Meeting in London 31 August First Interim Board Meeting September/October (TBD) First Scientific Advisory Committee Meeting 11-12 September G7 Health Ministers' Meeting Side Event 10 November Interim Board Meeting in India 17-20 January, 2017 Launch Partnership at the World Economic Forum Annual Meeting in Davos Organisation Peter Piot (Chair) Arnaud Bernaert Director Member of the Executive Committee Chief Executive Officer Directeur General de I'Institut Pasteur et President de la Fondation Paster Suisse Olivier Brandicourt Christian Brechot Seth Berkley Borge Brende Francis S. Collins Chief Executive Officer Minister of Foreign Affairs Director Steve Davis President and Chief Executive Officer Victor Dzau President Ruxundra Draghia-Akli Jeremy Farrar Anthony Fauci Mark Feinberg Thomas Frieden Julie Gerberding Director Director President and Chief Executive Officer Director and Population Health Head of Global Health and Healthcare Industries, Director of the health Directorate at the Research DG London School of Hygiene and Tropical Medicine World Economic Forum Sanofi Institut Pasteur GAVI Ministry of Foreign Affairs, Norway National Institute of Health PATH National Academy of Medicine EU Commission Wellcome Trust NIH IAVI cpc Vice-President, Strategic Communications, Global Public Policy MSD Tore Godal Special Advisor MFA Norway Peter Hale Executive Director Foundation for Vaccine Research Jane Halton Secretary Department of Finance, Australia Richard Hatchett Director BARDA Marie-Paule Kieny Assistant Director-General, Health Systems and Innovation WHO. Joanne Liu International President MSF Adel Mahmoud Susan McAdams Trevor Mundel Director Director of Multilateral and Innovative Financing President, Global health Programme Ngozi Okonjo-lweala Chair Stanley Plotkin Adar Poonawalla Emeritus Professor Chief Executive Officer Vijay Raghavan John-Arne Rottingen Secretary Executive Director, Infection Control and Environmental Health Susan Silbermann Paul Stoffels President, Pfizer Vaccines Worldwide Chairman, Pharmaceuticals; Chief Scientific Office Christophe Weber President and Chief Executive Officer Andrew Witty Chief Executive Officer Princeton University World Bank Group Gates Foundation GAVI UPENN Serum Institute of India DBT India NIPH Pfizer Johnson & Johnson Takeda GlaxoSmithKline